CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,956 | $24.58 | $146K | 109,711 |
| 2026-03-31 | Bellon Christine Chief Legal Officer | Grant or award | +20,000 | 115,667 | ||
| 2026-01-31 | Bellon Christine Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-01-22 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,371 | $34.00 | $47K | 95,667 |
| 2026-01-15 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −2,111 | $33.62 | $71K | 113,556 |
| 2026-01-15 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −15,959 | $34.72 | $554K | 97,597 |
| 2026-01-15 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −559 | $35.40 | $20K | 97,038 |
| 2025-12-31 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,254 | $27.10 | $34K | 115,667 |
| 2025-10-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −373 | $24.53 | $9K | 116,921 |
| 2025-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,674 | $18.35 | $104K | 117,294 |
| 2025-03-31 | Bellon Christine Chief Legal Officer | Grant or award | +20,000 | 122,968 | ||
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise 10b5-1 | +9,492 | $7.22 | $69K | 112,460 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise 10b5-1 | +508 | $7.22 | $4K | 112,968 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −10,000 | $34.00 | $340K | 102,968 |
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,492 | 0 | ||
| 2025-02-14 | Bellon Christine Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −508 | 10,410 | ||
| 2025-01-31 | Bellon Christine Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-02 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −1,241 | $24.68 | $31K | 102,968 |
| 2024-10-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −385 | $23.48 | $9K | 104,209 |
| 2024-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −3,401 | $32.12 | $109K | 104,594 |
Page 1 of 2 · 37 trades